News

Avidity Biosciences, Inc. (RNA) Initiated with a Strong Buy at Raymond James
Avidity Biosciences, Inc. (NASDAQ:RNA) is one of the 13 Biotech Stocks with Huge Upside Potential. Raymond James has started ...
Avidity Biosciences Touts Encouraging Functional Gains And Biomarker Reductions In Rare Muscular Weakness Disease Trial
Avidity Biosciences, Inc. (NASDAQ:RNA) revealed topline data from the dose escalation cohorts of the delpacibart braxlosiran ...
Fintel on MSN4d
Raymond James Initiates Coverage of Avidity Biosciences (RNA) with Strong Buy Recommendation
Fintel reports that on June 11, 2025, Raymond James initiated coverage of Avidity Biosciences (NasdaqGM:RNA) with a Strong ...
1RNA : The Analyst Verdict: Avidity Biosciences In The Eyes Of 12 Experts
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $65.42, along with a high estimate of $75.00 and a low estimate of $54.00. Surpassing the ...
Morningstar5d
Avidity Biosciences to Present Topline Data from Phase 1/2 FORTITUDE™ Trial of Del-brax in People Living with Facioscapulohumeral Muscular Dystrophy at 32nd Annual FSHD ...
SOURCE Avidity Biosciences, Inc. The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered ...
Avidity Biosciences (RNA) Gets a Buy from Barclays
Detailed price information for Avidity Biosciences Inc (RNA-Q) from The Globe and Mail including charting and trades.
Avidity Biosciences (RNA) Receives a Buy from Scotiabank
Detailed price information for Avidity Biosciences Inc (RNA-Q) from The Globe and Mail including charting and trades.
Insider Monkey4d
Avidity Biosciences, Inc. (RNA) Initiated with a Strong Buy at Raymond James
Avidity Biosciences, Inc. (NASDAQ:RNA) is one of the 13 Biotech Stocks with Huge Upside Potential. Raymond James has started coverage of Avidity Biosciences, Inc. (NASDAQ:RNA), with a Strong Buy ...